190 related articles for article (PubMed ID: 754609)
1. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)].
Ortonne JP; MacDonald DM; Micoud A; Thivolet J
Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609
[TBL] [Abstract][Full Text] [Related]
2. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
Ortonne JP; MacDonald DM; Micoud A; Thivolet J
Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
[TBL] [Abstract][Full Text] [Related]
3. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles.
Ortonne JP; Schmitt D; Thivolet J
J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the follicular melanocytes in the repigmented area of vitiligo after PUVA treatment (author's transl)].
Fukuda S
Nihon Hifuka Gakkai Zasshi; 1979 Apr; 89(5):355-67. PubMed ID: 313465
[No Abstract] [Full Text] [Related]
5. [Oral photochemotherapy in vitiligo (author's transl)].
Ortonne JP; Sannwald C; Thivolet J
Ann Dermatol Venereol; 1978; 105(6-7):617-24. PubMed ID: 736430
[TBL] [Abstract][Full Text] [Related]
6. Treatment of vitiligo with oral methoxsalen and UVA.
Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
[TBL] [Abstract][Full Text] [Related]
7. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
Dogra S; Kumar B
Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analytical study of the effects of psoralens in vitiligo (findings in 70 patients) (author's transl)].
Bouattour H; Chaabouni M
Ann Dermatol Venereol; 1978 May; 105(5):507-10. PubMed ID: 707943
[TBL] [Abstract][Full Text] [Related]
9. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
10. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
Pathak MA; Mosher DB; Fitzpatrick TB
Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
[TBL] [Abstract][Full Text] [Related]
11. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
12. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
Abdel-Naser MB; Hann SK; Bystryn JC
Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
[TBL] [Abstract][Full Text] [Related]
13. Patterns of repigmentation in two cases of hypopigmented type of vitiligo.
Anbar TS; El-Sawy AE; Attia SK; Moftah NH; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):156-8. PubMed ID: 19438996
[TBL] [Abstract][Full Text] [Related]
14. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
Vanscheidt W; Hunziker T
Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
[TBL] [Abstract][Full Text] [Related]
15. Determination of optimal topical photochemotherapy for vitiligo.
Grimes PE; Minus HR; Chakrabarti SG; Enterline J; Halder R; Gough JE; Kenney JA
J Am Acad Dermatol; 1982 Dec; 7(6):771-8. PubMed ID: 7174915
[TBL] [Abstract][Full Text] [Related]
16. In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy.
Lei TC; Vieira WD; Hearing VJ
Pigment Cell Res; 2002 Dec; 15(6):426-32. PubMed ID: 12453184
[TBL] [Abstract][Full Text] [Related]
17. Role of hair follicles in the repigmentation of vitiligo.
Cui J; Shen LY; Wang GC
J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
[TBL] [Abstract][Full Text] [Related]
18. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
[TBL] [Abstract][Full Text] [Related]
19. Acral lesions of vitiligo: why are they resistant to photochemotherapy?
Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425
[TBL] [Abstract][Full Text] [Related]
20. The pigmentary response to photochemotherapy.
Zaynoun S; Konrad K; Gschnait F; Wolff K
Acta Derm Venereol; 1977; 57(5):431-40. PubMed ID: 73310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
